Stem Point Capital LP Ark Genomic Revolution ETF (De Transaction History
Stem Point Capital LP
- $334 Billion
- Q3 2024
A detailed history of Stem Point Capital LP transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Stem Point Capital LP holds 5,000 shares of ARKG stock, worth $122,050. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,000Holding current value
$122,050% of portfolio
0.1%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$72.1 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$70.9 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$59.3 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$44.2 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$41 Million0.03% of portfolio